REFERENCES
1. Jankovic N, Geelen A, Streppel MT, et al. WHO guidelines for a
healthy diet and mortality from cardiovascular disease in European and
American elderly: the CHANCES project. Am J Clin Nutr 2015; 102:
745-756. 2015/09/12. DOI: 10.3945/ajcn.114.095117.
2. Mortality GBD and Causes of Death C. Global, regional, and national
life expectancy, all-cause mortality, and cause-specific mortality for
249 causes of death, 1980-2015: a systematic analysis for the Global
Burden of Disease Study 2015. Lancet 2016; 388: 1459-1544.
2016/10/14. DOI: 10.1016/S0140-6736(16)31012-1.
3. Rafieian-Kopaei M, Setorki M, Doudi M, et al. Atherosclerosis:
process, indicators, risk factors and new hopes. Int J Prev Med2014; 5: 927-946. 2014/12/10.
4. Berenson GS, Srinivasan SR, Bao W, et al. Association between
multiple cardiovascular risk factors and atherosclerosis in children and
young adults. The Bogalusa Heart Study. The New England journal of
medicine 1998; 338: 1650-1656. 1998/06/06. DOI:
10.1056/NEJM199806043382302.
5. Acarturk E, Demir M and Kanadasi M. Aortic atherosclerosis is a
marker for significant coronary artery disease. Jpn Heart J 1999;
40: 775-781. 2000/03/29. DOI: 10.1536/jhj.40.775.
6. Sahadevan M, Chee KH and Tai MS. Prevalence of extracranial carotid
atherosclerosis in the patients with coronary artery disease in a
tertiary hospital in Malaysia. Medicine (Baltimore) 2019; 98:
e15082. 2019/04/16. DOI: 10.1097/MD.0000000000015082.
7. Suh B, Song YS, Shin DW, et al. Incidentally detected atherosclerosis
in the abdominal aorta or its major branches on computed tomography is
highly associated with coronary heart disease in asymptomatic adults.J Cardiovasc Comput Tomogr 2018; 12: 305-311. 2018/03/27. DOI:
10.1016/j.jcct.2018.03.001.
8. Drozd J, Jargiełło T, Opalińska E, et al. Choroba naczyń wieńcowych a
zmiany miażdżycowe w tętnicach szyjnych oceniane metodą biopsji
ultradźwiękowej. Folia Cardiologica 2003; 10: 759–767.
9. Khoury Z, Schwartz R, Gottlieb S, et al. Relation of coronary artery
disease to atherosclerotic disease in the aorta, carotid, and femoral
arteries evaluated by ultrasound. Am J Cardiol 1997; 80:
1429-1433. 1997/12/17. DOI: 10.1016/s0002-9149(97)00701-7.
10. Aboyans V and Lacroix P. Indications for carotid screening in
patients with coronary artery disease. Presse Med 2009; 38:
977-986. 2009/04/21. DOI: 10.1016/j.lpm.2009.02.015.
11. Rangel A, Albarran H, Solorio S, et al. Angiographic concurrence of
coronary artery disease and aortoiliac lesions. Angiology 2002;
53: 685-692. 2002/12/05. DOI: 10.1177/000331970205300609.
12. Rigatelli G. Aortoiliac angiography during coronary artery
angiography detects significant occult aortoiliac and renal artery
atherosclerosis in patients with coronary atherosclerosis. Int J
Cardiovasc Imaging 2004; 20: 299-303. 2004/11/09. DOI:
10.1023/b:caim.0000041948.14956.44.
13. Rigatelli G and Rigatelli G. Malpractice in invasive cardiology: is
angiography of abdominal aorta or subclavian artery appropriate in
patients undergoing coronary angiography? A meta analysis. Int J
Cardiovasc Imaging 2005; 21: 591-598. 2005/12/03. DOI:
10.1007/s10554-005-3753-y.
14. Imori Y, Akasaka T, Ochiai T, et al. Co-existence of carotid artery
disease, renal artery stenosis, and lower extremity peripheral arterial
disease in patients with coronary artery disease. Am J Cardiol2014; 113: 30-35. DOI: 10.1016/j.amjcard.2013.09.015.
15. Puz P, Lasek-Bal A, Warsz-Wianecka A, et al. Prevalence of
atherosclerotic stenosis of the carotid and cerebral arteries in
patients with stable or unstable coronary artery disease. Pol Arch
Intern Med 2020; 130: 412-419. 2020/05/02. DOI: 10.20452/pamw.15330.
16. Tanimoto S, Ikari Y, Tanabe K, et al. Prevalence of carotid artery
stenosis in patients with coronary artery disease in Japanese
population. Stroke 2005; 36: 2094-2098. 2005/09/24. DOI:
10.1161/01.STR.0000185337.82019.9e.
17. Saleh A, Makhamreh H, Qoussoos T, et al. Prevalence of previously
unrecognized peripheral arterial disease in patients undergoing coronary
angiography. Medicine (Baltimore) 2018; 97: e11519. 2018/07/20.
DOI: 10.1097/MD.0000000000011519.
18. Park S, Jung JH, Seo HS, et al. The prevalence and clinical
predictors of atherosclerotic renal artery stenosis in patients
undergoing coronary angiography. Heart Vessels 2004; 19: 275-279.
2005/04/01. DOI: 10.1007/s00380-004-0789-1.
19. Makowsky MJ, McAlister FA, Galbraith PD, et al. Lower extremity
peripheral arterial disease in individuals with coronary artery disease:
prognostic importance, care gaps, and impact of therapy. Am Heart
J 2008; 155: 348-355. 2008/01/25. DOI: 10.1016/j.ahj.2007.09.005.
20. Dzielinska Z, Januszewicz A, Demkow M, et al. Cardiovascular risk
factors in hypertensive patients with coronary artery disease and
coexisting renal artery stenosis. J Hypertens 2007; 25: 663-670.
DOI: 10.1097/HJH.0b013e328011dc6c.
21. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the
diagnosis and management of chronic coronary syndromes. Eur Heart
J 2020; 41: 407-477. 2019/09/11. DOI: 10.1093/eurheartj/ehz425.
22. Steinl DC and Kaufmann BA. Ultrasound imaging for risk assessment in
atherosclerosis. Int J Mol Sci 2015; 16: 9749-9769. 2015/05/06.
DOI: 10.3390/ijms16059749.
23. Fernandez-Friera L, Penalvo JL, Fernandez-Ortiz A, et al.
Prevalence, Vascular Distribution, and Multiterritorial Extent of
Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA
(Progression of Early Subclinical Atherosclerosis) Study.Circulation 2015; 131: 2104-2113. 2015/04/18. DOI:
10.1161/CIRCULATIONAHA.114.014310.
24. Spacek M, Zemanek D, Hutyra M, et al. Vulnerable atherosclerotic
plaque - a review of current concepts and advanced imaging. Biomed
Pap Med Fac Univ Palacky Olomouc Czech Repub 2018; 162: 10-17.
2018/02/23. DOI: 10.5507/bp.2018.004.
25. Steinvil A, Sadeh B, Bornstein NM, et al. Impact of carotid
atherosclerosis on the risk of adverse cardiac events in patients with
and without coronary disease. Stroke 2014; 45: 2311-2317.
2014/06/19. DOI: 10.1161/STROKEAHA.114.005663.
26. Vranic H, Hadzimehmedagic A, Haxibeqiri-Karabdic I, et al. Critical
Carotid Artery Stenosis in Coronary and Non-Coronary Patients -
Frequency of Risk Factors. Med Arch 2017; 71: 110-114.
2017/08/10. DOI: 10.5455/medarh.2017.71.110-114.
27. He J, Chen P, Luo Y, et al. Relationship between the maximum carotid
plaque area and the severity of coronary atherosclerosis. Int
Angiol 2018; 37: 300-309. 2018/03/10. DOI:
10.23736/S0392-9590.18.03967-6.
28. Zhu Y, You J, Xu C, et al. Predictive value of carotid artery
ultrasonography for the risk of coronary artery disease. J Clin
Ultrasound 2021; 49: 218-226. 2020/10/15. DOI: 10.1002/jcu.22932.
29. Morito N, Inoue Y, Urata M, et al. Increased carotid artery plaque
score is an independent predictor of the presence and severity of
coronary artery disease. J Cardiol 2008; 51: 25-32. 2008/06/05.
DOI: 10.1016/j.jjcc.2007.09.003.
30. Kanadasi M, Cayli M, San M, et al. The presence of a calcific plaque
in the common carotid artery as a predictor of coronary atherosclerosis.Angiology 2006; 57: 585-592. 2006/10/28. DOI:
10.1177/0003319706293123.
31. Bytyci I, Shenouda R, Wester P, et al. Carotid Atherosclerosis in
Predicting Coronary Artery Disease: A Systematic Review and
Meta-Analysis. Arterioscler Thromb Vasc Biol 2021; 41: e224-e237.
2021/02/26. DOI: 10.1161/ATVBAHA.120.315747.
32. Brook RD, Bard RL, Patel S, et al. A negative carotid plaque area
test is superior to other noninvasive atherosclerosis studies for
reducing the likelihood of having underlying significant coronary artery
disease. Arterioscler Thromb Vasc Biol 2006; 26: 656-662.
2005/12/17. DOI: 10.1161/01.ATV.0000200079.18690.60.
33. Ikeda N, Kogame N, Iijima R, et al. Carotid artery intima-media
thickness and plaque score can predict the SYNTAX score. Eur Heart
J 2012; 33: 113-119. 2011/10/27. DOI: 10.1093/eurheartj/ehr399.
34. Chang CC, Chang ML, Huang CH, et al. Carotid intima-media thickness
and plaque occurrence in predicting stable angiographic coronary artery
disease. Clin Interv Aging 2013; 8: 1283-1288. 2013/10/08. DOI:
10.2147/CIA.S49166.
35. Akazawa S, Tojikubo M, Nakano Y, et al. Usefulness of carotid plaque
(sum and maximum of plaque thickness) in combination with intima-media
thickness for the detection of coronary artery disease in asymptomatic
patients with diabetes. J Diabetes Investig 2016; 7: 396-403.
2016/06/23. DOI: 10.1111/jdi.12403.
36. Chung J-W. Association between Carotid Artery Plaque Score and
SYNTAX Score in Coronary Artery Disease Patients. General
Medicine: Open Access 2017; 5. DOI: 10.4172/2327-5146.1000301.
37. Sirimarco G, Amarenco P, Labreuche J, et al. Carotid atherosclerosis
and risk of subsequent coronary event in outpatients with
atherothrombosis. Stroke 2013; 44: 373-379. 2013/01/12. DOI:
10.1161/STROKEAHA.112.673129.
38. Ozcaglayan O, K TI, Gur DO, et al. Carotid arteries and
vertebrobasilary system intracranial stenosis correlates with multi
vessel coronary artery disease. Bratisl Lek Listy 2019; 120:
362-367. 2019/05/23. DOI: 10.4149/BLL_2019_059.
39. Molnar S, Kerenyi L, Ritter MA, et al. Correlations between the
atherosclerotic changes of femoral, carotid and coronary arteries: a
post mortem study. J Neurol Sci 2009; 287: 241-245. 2009/08/18.
DOI: 10.1016/j.jns.2009.06.001.
40. Grubic N, Colledanchise KN, Liblik K, et al. The Role of Carotid and
Femoral Plaque Burden in the Diagnosis of Coronary Artery Disease.Curr Cardiol Rep 2020; 22: 121. 2020/08/12. DOI:
10.1007/s11886-020-01375-1.
41. Johri AM, Behl P, Hetu MF, et al. Carotid Ultrasound Maximum Plaque
Height-A Sensitive Imaging Biomarker for the Assessment of Significant
Coronary Artery Disease. Echocardiography 2016; 33: 281-289.
2015/07/01. DOI: 10.1111/echo.13007.
42. Spence JD. Ultrasound Measurement of Carotid Plaque as a Surrogate
Outcome for Coronary Artery Disease. Am J Cardiol 2002;
89(suppl): 10B–16B.
43. Johri AM, Nambi V, Naqvi TZ, et al. Recommendations for the
Assessment of Carotid Arterial Plaque by Ultrasound for the
Characterization of Atherosclerosis and Evaluation of Cardiovascular
Risk: From the American Society of Echocardiography. J Am Soc
Echocardiogr 2020; 33: 917-933. 2020/07/01. DOI:
10.1016/j.echo.2020.04.021.
44. Peters SA, den Ruijter HM, Bots ML, et al. Improvements in risk
stratification for the occurrence of cardiovascular disease by imaging
subclinical atherosclerosis: a systematic review. Heart 2012; 98:
177-184. 2011/11/19. DOI: 10.1136/heartjnl-2011-300747.
45. Zhao Q, Zhao X, Cai Z, et al. Correlation of coronary plaque
phenotype and carotid atherosclerotic plaque composition. Am J Med
Sci 2011; 342: 480-485. 2011/06/18. DOI: 10.1097/MAJ.0b013e31821caa88.
46. Bos D, Arshi B, van den Bouwhuijsen QJA, et al. Atherosclerotic
Carotid Plaque Composition and Incident Stroke and Coronary Events.J Am Coll Cardiol 2021; 77: 1426-1435. 2021/03/20. DOI:
10.1016/j.jacc.2021.01.038.
47. Uematsu M, Nakamura T, Horikoshi T, et al. Echolucency of carotid
plaque is useful for selecting high-risk patients with chronic coronary
artery disease who benefit from intensive lipid-lowering therapy.J Cardiol 2021; 77: 590-598. 2021/01/28. DOI:
10.1016/j.jjcc.2021.01.002.
48. Nakamura J, Nakamura T, Deyama J, et al. Assessment of carotid
plaque neovascularization using quantitative analysis of
contrast-enhanced ultrasound imaging is useful for risk stratification
in patients with coronary artery disease. Int J Cardiol 2015;
195: 113-119. 2015/05/31. DOI: 10.1016/j.ijcard.2015.05.107.
49. Jashari F, Ibrahimi P, Nicoll R, et al. Coronary and carotid
atherosclerosis: similarities and differences. Atherosclerosis2013; 227: 193-200. 2012/12/12. DOI:
10.1016/j.atherosclerosis.2012.11.008.
50. Dweck MR, Puntman V, Vesey AT, et al. MR Imaging of Coronary
Arteries and Plaques. JACC Cardiovasc Imaging 2016; 9: 306-316.
2016/03/12. DOI: 10.1016/j.jcmg.2015.12.003.
51. Bauersachs R, Zeymer U, Brière JB, et al. Burden of Coronary Artery
Disease and Peripheral Artery Disease: A Literature Review.Cardiovasc Ther 2019; 2019: 8295054. 2020/02/27. DOI:
10.1155/2019/8295054.
52. Aday AW and Matsushita K. Epidemiology of Peripheral Artery Disease
and Polyvascular Disease. Circ Res 2021; 128: 1818-1832.
2021/06/11. DOI: 10.1161/circresaha.121.318535.
53. Cho SW, Kim BG, Kim DH, et al. Prediction of coronary artery disease
in patients with lower extremity peripheral artery disease. Int
Heart J 2015; 56: 209-212. 2015/03/06. DOI: 10.1536/ihj.14-284.
54. Kumar A, Bano S, Bhurgri U, et al. Peripheral Artery Disease as a
Predictor of Coronary Artery Disease in Patients Undergoing Coronary
Angiography. Cureus 2021; 13: e15094. 2021/06/24. DOI:
10.7759/cureus.15094.
55. Moussa ID, Jaff MR, Mehran R, et al. Prevalence and prediction of
previously unrecognized peripheral arterial disease in patients with
coronary artery disease: the Peripheral Arterial Disease in
Interventional Patients Study. Catheter Cardiovasc Interv 2009;
73: 719-724. 2009/02/13. DOI: 10.1002/ccd.21969.
56. Belcaro G, Nicolaides AN, Ramaswami G, et al. Carotid and femoral
ultrasound morphology screening and cardiovascular events in low risk
subjects: a 10-year follow-up study (the CAFES-CAVE study(1)).Atherosclerosis 2001; 156: 379-387. 2001/06/08. DOI:
10.1016/s0021-9150(00)00665-1.
57. Cournot M, Bura A, Cambou JP, et al. Arterial ultrasound screening
as a tool for coronary risk assessment in asymptomatic men and women.Angiology 2012; 63: 282-288. 2011/08/30. DOI:
10.1177/0003319711414865.
58. Kocyigit D, Gurses KM, Taydas O, et al. Role of femoral artery
ultrasound imaging in cardiovascular event risk prediction in a primary
prevention cohort at a medium-term follow-up. J Cardiol 2020; 75:
537-543. 2019/10/21. DOI: 10.1016/j.jjcc.2019.09.012.
59. Laclaustra M, Casasnovas JA, Fernandez-Ortiz A, et al. Femoral and
Carotid Subclinical Atherosclerosis Association With Risk Factors and
Coronary Calcium: The AWHS Study. J Am Coll Cardiol 2016; 67:
1263-1274. 2016/03/19. DOI: 10.1016/j.jacc.2015.12.056.
60. Santoro L, Ferraro PM, Flex A, et al. New semiquantitative
ultrasonographic score for peripheral arterial disease assessment and
its association with cardiovascular risk factors. Hypertens Res2016; 39: 868-873. 2016/07/15. DOI: 10.1038/hr.2016.88.
61. Santoro L, Flex A, Nesci A, et al. Association between peripheral
arterial disease and cardiovascular risk factors: role of
ultrasonography versus ankle-brachial index. Eur Rev Med Pharmacol
Sci 2018; 22: 3160-3165. 2018/06/05. DOI:
10.26355/eurrev_201805_15076.
62. Colledanchise KN, Mantella LE, Hétu MF, et al. Femoral plaque burden
by ultrasound is a better indicator of significant coronary artery
disease over ankle brachial index. Int J Cardiovasc Imaging 2021;
37: 2965-2973. 2021/07/10. DOI: 10.1007/s10554-021-02334-9.
63. Kafetzakis A, Kochiadakis G, Laliotis A, et al. Association of
subclinical wall changes of carotid, femoral, and popliteal arteries
with obstructive coronary artery disease in patients undergoing coronary
angiography. Chest 2005; 128: 2538-2543. 2005/10/21. DOI:
10.1378/chest.128.4.2538.
64. Kirhmajer MV, Banfic L, Vojkovic M, et al. Correlation of femoral
intima-media thickness and the severity of coronary artery disease.Angiology 2011; 62: 134-139. 2010/08/14. DOI:
10.1177/0003319710375087.
65. Srámek A, Bosch JG, Reiber JH, et al. Ultrasound assessment of
atherosclerotic vessel wall changes: reproducibility of intima-media
thickness measurements in carotid and femoral arteries. Invest
Radiol 2000; 35: 699-706. 2001/02/24. DOI:
10.1097/00004424-200012000-00001.
66. Colledanchise KN, Mantella LE, Bullen M, et al. Combined Femoral and
Carotid Plaque Burden Identifies Obstructive Coronary Artery Disease in
Women. J Am Soc Echocardiogr 2020; 33: 90-100. 2019/10/15. DOI:
10.1016/j.echo.2019.07.024.
67. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10
years in patients with peripheral arterial disease. The New
England journal of medicine 1992; 326: 381-386. 1992/02/06. DOI:
10.1056/NEJM199202063260605.
68. Criqui MH, McClelland RL, McDermott MM, et al. The ankle-brachial
index and incident cardiovascular events in the MESA (Multi-Ethnic Study
of Atherosclerosis). J Am Coll Cardiol 2010; 56: 1506-1512.
2010/10/19. DOI: 10.1016/j.jacc.2010.04.060.
69. Gunenc Beser C, Karcaaltincaba M, Celik HH, et al. The prevalence
and distribution of the atherosclerotic plaques in the abdominal aorta
and its branches. Folia Morphol (Warsz) 2016; 75: 364-375.
2016/01/30. DOI: 10.5603/FM.a2016.0005.
70. Li W, Luo S, Luo J, et al. Association between abdominal aortic
plaque and coronary artery disease. Clin Interv Aging 2016; 11:
683-688. 2016/06/10. DOI: 10.2147/CIA.S104425.
71. Kronzon I and Tunick PA. Aortic atherosclerotic disease and stroke.Circulation 2006; 114: 63-75. 2006/07/05. DOI:
10.1161/CIRCULATIONAHA.105.593418.
72. Meissner I, Khandheria BK, Sheps SG, et al. Atherosclerosis of the
aorta: risk factor, risk marker, or innocent bystander? A prospective
population-based transesophageal echocardiography study. J Am Coll
Cardiol 2004; 44: 1018-1024. 2004/09/01. DOI:
10.1016/j.jacc.2004.05.075.
73. Fazio G, Redberg R, Winslow T, et al. Transesophageal
echocardiographically detected atherosclerotic aortic plaque is a marker
for coronary artery disease. J Am Coll Cardiol 1993; 21: 144-150.
74. Parthenakis F, Skalidis E, Simantirakis E, et al. Absence of
atherosclerotic lesions in the thoracic aorta indicates absence of
significant coronary artery disease. Am J Cardiol 1996; 77:
1118-1121 SERIALS SUBS JAF. 1996/05/15. DOI:
10.1016/s0002-9149(96)00146-4.
75. Davila-Roman VG, Murphy SF, Nickerson NJ, et al. Atherosclerosis of
the ascending aorta is an independent predictor of long-term neurologic
events and mortality. J Am Coll Cardiol 1999; 33: 1308-1316.
1999/04/08. DOI: 10.1016/s0735-1097(99)00034-0.
76. Rangaswami J, Bhalla V, Blair JEA, et al. Cardiorenal Syndrome:
Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A
Scientific Statement From the American Heart Association.Circulation 2019; 139: e840-e878. 2019/03/12. DOI:
10.1161/CIR.0000000000000664.
77. Ollivier R, Boulmier D, Veillard D, et al. Frequency and predictors
of renal artery stenosis in patients with coronary artery disease.Cardiovasc Revasc Med 2009; 10: 23-29. DOI:
10.1016/j.carrev.2008.06.003.
78. Jean WJ, al-Bitar I, Zwicke DL, et al. High incidence of renal
artery stenosis in patients with coronary artery disease. Cathet
Cardiovasc Diagn 1994; 32: 8-10.
79. Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery
stenosis among a prospective cohort of hypertensive patients undergoing
coronary angiography. Mayo Clin Proc 2002; 77: 309-316.
2002/04/09. DOI: 10.4065/77.4.309.
80. Valentine RJ, Clagett GP, Miller GL, et al. The coronary risk of
unsuspected renal artery stenosis. J Vasc Surg 1993; 18: 433-439;
discussion 439-440. 1993/09/01.
81. Conlon PJ, Little MA, Pieper K, et al. Severity of renal vascular
disease predicts mortality in patients undergoing coronary angiography.Kidney Int 2001; 60: 1490-1497. DOI:
10.1046/j.1523-1755.2001.00953.x.
82. Gross CM, Kramer J, Waigand J, et al. Relation between
arteriosclerosis in the coronary and renal arteries. Am J Cardiol1997; 80: 1478-1481. 1997/12/17. DOI: 10.1016/s0002-9149(97)00727-3.
83. Liang F, Hu DY, Wu MY, et al. The incidence of renal artery stenosis
in the patients referred for coronary artery bypass grafting.Indian J Nephrol 2012; 22: 13-17. DOI: 10.4103/0971-4065.91181.
84. Przewłocki T, Kabłak-Ziembicka A, Tracz W, et al. Renal artery
stenosis in patients with coronary artery disease. Kardiol Pol2008; 66: 856-862.
85. Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular
disease in United States patients aged 67 years or older: risk factors,
revascularization, and prognosis. Kidney Int 2005; 68: 293-301.
DOI: 10.1111/j.1523-1755.2005.00406.x.
86. Safak E, Wilke C, Derer W, et al. Long-term follow-up of patients
with atherosclerotic renal artery disease. Journal of the American
Society of Hypertension : JASH 2013; 7: 24-31. 2013/01/17. DOI:
10.1016/j.jash.2012.12.001.
87. Zanoli L, Rastelli S, Marcantoni C, et al. Non-hemodynamically
significant renal artery stenosis predicts cardiovascular events in
persons with ischemic heart disease. Am J Nephrol 2014; 40:
468-477. DOI: 10.1159/000368913.
88. Edwards MS, Craven TE, Burke GL, et al. Renovascular disease and the
risk of adverse coronary events in the elderly: a prospective,
population-based study. Arch Intern Med 2005; 165: 207-213. DOI:
10.1001/archinte.165.2.207.
89. Griffin M, Nicolaides A, Tyllis T, et al. Carotid and femoral
arterial wall changes and the prevalence of clinical cardiovascular
disease. Vasc Med 2009; 14: 227-232. 2009/08/05. DOI:
10.1177/1358863x08101542.
90. Tartiere JM, Henry OF, Safar H, et al. Carotid intima-media
thickness and carotid and/or iliofemoral plaques: comparison of two
markers of cardiovascular risk in hypertensive patients. J
Hypertens 2003; 21: 739-746. 2003/03/27. DOI:
10.1097/01.hjh.0000052494.18130.80.
91. Yerly P, Marques-Vidal P, Owlya R, et al. The atherosclerosis burden
score (ABS): a convenient ultrasound-based score of peripheral
atherosclerosis for coronary artery disease prediction. J
Cardiovasc Transl Res 2015; 8: 138-147. 2015/03/17. DOI:
10.1007/s12265-015-9617-5.
92. Lehrke S, Egenlauf B, Steen H, et al. Prediction of coronary artery
disease by a systemic atherosclerosis score index derived from
whole-body MR angiography. J Cardiovasc Magn Reson 2009; 11: 36.
2009/09/19. DOI: 10.1186/1532-429X-11-36.
93. Dodge M and Movahed MR. Screening of the Abdominal Aorta During
Routine Echocardiographic Examination Is Cost-effective and Leads to
Increase in Statin Utilization by Detecting Subclinical Atherosclerosis.Crit Pathw Cardiol 2021; 20: 1-3. 2020/08/10. DOI:
10.1097/HPC.0000000000000237.